Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy – unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease
- 23 April 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (7-8) , 524-525
- https://doi.org/10.1007/s00431-001-0859-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The Role of Neurogenetics in Gaucher DiseaseArchives of Neurology, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- LONG-TERM FOLLOW-UP OF THE FIRST SUCCESSFUL BONE MARROW TRANSPLANTATION IN GAUCHER DISEASETransplantation, 1988
- Lysosphingolipids Inhibit Protein Kinase C: Implications for the SphingolipidosesScience, 1987